rxstat › Shortages › Etonogestrel Ethinyl Estradiol
Etonogestrel Ethinyl Estradiol shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Etonogestrel Ethinyl Estradiol products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 31, 2026.
In shortage since
Dec 1, 2025
Est. full return
Jul 31, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageHALOETTE
11.7MG
2.7MG · RING (SLOW-RELEASE) · SEARCHLIGHT PHARMA INC
DIN 02520028 · since Dec 1, 2025, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
ResolvedNUVARING
11.4MG
2.6MG · RING (SLOW-RELEASE) · ORGANON CANADA INC.
DIN 02253186 · ended Mar 4, 2026 · Demand increase for the drug.
ResolvedNUVARING
2.6MG
11.4MG · RING (SLOW-RELEASE) · ORGANON CANADA INC.
DIN 02253186 · ended Jun 27, 2023 · Delay in shipping of the drug.
AvoidedNUVARING
2.6MG
11.4MG · RING (SLOW-RELEASE) · MERCK CANADA INC
DIN 02253186 · ended Feb 4, 2020 · Delay in shipping of the drug.
ResolvedNUVARING
2.6MG
11.4MG · RING (SLOW-RELEASE) · MERCK CANADA INC
DIN 02253186 · ended Dec 19, 2019 · Delay in shipping of the drug.
AvoidedNUVARING
2.6MG
11.4MG · RING (SLOW-RELEASE) · MERCK CANADA INC
DIN 02253186 · ended Jan 15, 2019 · Delay in shipping of the drug.
ResolvedNUVARING
2.6MG
11.4MG · RING (SLOW-RELEASE) · MERCK CANADA INC
DIN 02253186 · ended Jan 4, 2019 · Delay in shipping of the drug.
ResolvedNUVARING
2.6MG
11.4MG · RING (SLOW-RELEASE) · MERCK CANADA INC
DIN 02253186 · ended Dec 19, 2018 · Delay in shipping of the drug.
ResolvedNUVARING
2.6MG
11.4MG · RING (SLOW-RELEASE) · MERCK CANADA INC
DIN 02253186 · ended Nov 26, 2018 · Delay in shipping of the drug.
ResolvedNUVARING
2.6MG
11.4MG · RING (SLOW-RELEASE) · MERCK CANADA INC
DIN 02253186 · ended Jul 13, 2018 · Delay in shipping of the drug.
AvoidedNUVARING
2.6MG
11.4MG · RING (SLOW-RELEASE) · MERCK CANADA INC
DIN 02253186 · ended Mar 29, 2017 · Delay in shipping of the drug.
ResolvedNUVARING
2.6MG
11.4MG · RING (SLOW-RELEASE) · MERCK CANADA INC
DIN 02253186 · ended Oct 6, 2017 · Delay in shipping of the drug.
What's happening
Etonogestrel Ethinyl Estradiol is currently affected by an active shortage report filed with Health Canada by SEARCHLIGHT PHARMA INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Etonogestrel Ethinyl Estradiol is classified under “CONTRACEPTIVES FOR TOPICAL USE” (ATC G02BB).
Recent changes
Common questions
When will Etonogestrel Ethinyl Estradiol be back in stock in Canada?
The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Etonogestrel Ethinyl Estradiol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.